Tranexamic acid for chronic subdural hematomas
Treatments studied
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests if a medication called tranexamic acid can help treat chronic subdural hematomas (a type of bleeding on the brain) without surgery. It's for patients who have this condition but don't need immediate surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a chronic subdural hematoma (a blood collection on the brain) within the last 14 days.
- A neurosurgeon has determined that you do not need surgery for this condition.
- You can take study medications on time, or have a caregiver who can help you.
- You are not taking blood thinners for certain conditions like atrial fibrillation, and do not have a history of blood clots or bleeding disorders.
- Your kidneys are working well (no severe kidney disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving a medicine called tranexamic acid (TXA) during surgery helps prevent rebleeding after draining a chronic subdural hematoma. TXA helps stop bleeding, and the goal is to reduce the chance the hematoma comes back.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests if injecting bevacizumab into the artery that supplies the covering of the brain can help treat chronic subdural hematoma (a slow-growing collection of blood on the brain's surface). It may offer an alternative to surgery for some patients.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial tests if a special cold plasma treatment applied during surgery can reduce the chance of a chronic subdural hematoma (a slowly growing blood collection on the brain) from returning. It may help people who already need surgery for this condition.
This trial tests whether adding a drug called bevacizumab (given through an artery in the brain) to a standard procedure called middle meningeal artery embolization (MMAE) helps treat chronic subdural hematoma (a collection of blood on the brain's surface) better than the procedure alone. The study is for people scheduled for MMAE who meet specific size and symptom criteria.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.